Centessa Pharmaceuticals-adr (CNTA) Technical Analysis
$16.77▲1.57%
Market is closed - opens 7 PM, 20 Mar 2025
Insights
- Centessa Pharmaceuticals-adr is currently in a neutral trading position according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Centessa Pharmaceuticals-adr stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Centessa Pharmaceuticals-adr stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Centessa Pharmaceuticals-adr stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 49.63 | Neutral |
Stochastic | 56.42, 69.55 | Neutral |
Ultimate Oscillator | 51.09 | Neutral |
Stochastic Relative Strength Index | 88.53, 94.14 | Sell |
Moving Average Convergence Divergence | 0.07, -0.04 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 16.7 | Buy |
20 | 16.28 | Sell |
50 | 16.5 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 16.66 | Buy |
20 | 16.56 | Sell |
50 | 16.57 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 16.65 | Neutral |
20 | 16.27 | Neutral |
50 | 16.65 | Neutral |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 16.86 | Buy |
20 | 16.61 | Buy |
50 | 16.57 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 16.99 | Buy |
20 | 16.75 | Buy |
50 | 16.48 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 19.33 |
Resistance L2 | 18.5 |
Resistance L1 | 17.85 |
Pivot Point | 17.02 |
Support L1 | 16.37 |
Support L2 | 15.54 |
Support L3 | 14.89 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.